Maze Therapeutics (MAZE) Treasury Shares (2024 - 2025)

Maze Therapeutics (MAZE) reported Treasury Shares of $10372.0 for Q4 2025, down 100.0% on a YoY basis from $297.2 million in Q4 2024, and down 98.26% sequentially from $594825.0 in Q3 2025.

Maze Therapeutics (MAZE) Treasury Shares (2024 - 2025) Analysis & Trends

Maze Therapeutics (MAZE) has 2 years of Treasury Shares data on file, last reported at $10372.0 in Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares fell 100.0% year-over-year to $10372.0; the trailing twelve-month figure through Dec 2025 stood at $10372.0 (down 100.0% YoY), and the FY2025 full-year result was $10372.0, down 100.0% from the prior year.
  • Treasury Shares slipped to $10372.0 in Q4 2025, from $594825.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $297.2 million in Q4 2024 to a low of $10372.0 in Q4 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -21,709.08
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 265,401.92
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 19.41 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 5.14 Mn
10 Maze Therapeutics 1.49 Bn 1.49 Bn 18.21 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 10,372.00
Dec 31, 2025 10,372.00
Sep 30, 2025 594,825.00
Sep 30, 2025 594,825.00
Dec 31, 2024 297.21 Mn
Dec 31, 2024 297.21 Mn
Sep 30, 2024 203.42 Mn
Sep 30, 2024 203.42 Mn
Jun 30, 2024 203.42 Mn
Jun 30, 2024 203.42 Mn
Mar 31, 2024 203.42 Mn
Mar 31, 2024 203.42 Mn